Literature DB >> 11385371

The prognostic value of natural killer cell infiltration in resected pulmonary adenocarcinoma.

I Takanami1, K Takeuchi, M Giga.   

Abstract

OBJECTIVE: Natural cytotoxicity caused by mediated natural killer cells is believed to play an important role in host-cancer defense mechanisms. Immunohistochemically, we have detected natural killer cells in tissue specimens from patients with pulmonary adenocarcinoma and have assessed their clinical characteristics.
METHODS: Using the monoclonal antibody for CD57 specific marker for natural killer cells, we quantified natural killer cell infiltration in 150 patients with pulmonary adenocarcinoma who underwent curative tumor resection to investigate the relationship between natural killer cell counts and clinicopathologic factors and prognosis.
RESULTS: The natural killer cell count was significantly related to the regulation of tumor progression, involving T classification, N classification, and stage (P =.01 for T classification or stage; P =.02 for N classification). A significant difference in the rate of patient survival was detected between those patients whose tumors had either high or low natural killer cell counts in both the overall and stage I groups (P =.0002 for the overall group; P =.049 for the stage I group).
CONCLUSION: These data indicate that natural killer infiltration may contribute to the regulation of tumor progression and that the natural killer cell count can serve as a useful prognostic marker in overall and stage I pulmonary adenocarcinoma.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11385371     DOI: 10.1067/mtc.2001.113026

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  64 in total

Review 1.  The non-small cell lung cancer immune contexture. A major determinant of tumor characteristics and patient outcome.

Authors:  Romain Remark; Christian Becker; Jorge E Gomez; Diane Damotte; Marie-Caroline Dieu-Nosjean; Catherine Sautès-Fridman; Wolf-Herman Fridman; Charles A Powell; Nasser K Altorki; Miriam Merad; Sacha Gnjatic
Journal:  Am J Respir Crit Care Med       Date:  2015-02-15       Impact factor: 21.405

2.  Immunomodulatory Magnetic Microspheres for Augmenting Tumor-Specific Infiltration of Natural Killer (NK) Cells.

Authors:  Wooram Park; Andrew C Gordon; Soojeong Cho; Xiaoke Huang; Kathleen R Harris; Andrew C Larson; Dong-Hyun Kim
Journal:  ACS Appl Mater Interfaces       Date:  2017-04-17       Impact factor: 9.229

3.  IL15 induces a potent antitumor activity in NK cells isolated from malignant pleural effusions and overcomes the inhibitory effect of pleural fluid.

Authors:  D Croxatto; S Martini; L Chiossone; F Scordamaglia; C F Simonassi; L Moretta; M C Mingari; P Vacca
Journal:  Oncoimmunology       Date:  2017-02-17       Impact factor: 8.110

Review 4.  NK cells: key to success of DC-based cancer vaccines?

Authors:  Eva Lion; Evelien L J M Smits; Zwi N Berneman; Viggo F I Van Tendeloo
Journal:  Oncologist       Date:  2012-08-20

5.  Immune recruitment and therapeutic synergy: keys to optimizing oncolytic viral therapy?

Authors:  Jay D Naik; Christopher J Twelves; Peter J Selby; Richard G Vile; John D Chester
Journal:  Clin Cancer Res       Date:  2011-05-16       Impact factor: 12.531

6.  Nonblocking Monoclonal Antibody Targeting Soluble MIC Revamps Endogenous Innate and Adaptive Antitumor Responses and Eliminates Primary and Metastatic Tumors.

Authors:  Shengjun Lu; Jinyu Zhang; Dai Liu; Guangfu Li; Kevin F Staveley-O'Carroll; Zihai Li; Jennifer D Wu
Journal:  Clin Cancer Res       Date:  2015-06-23       Impact factor: 12.531

Review 7.  The Expanding Role of Natural Killer Cells in Type 1 Diabetes and Immunotherapy.

Authors:  Chris Fraker; Allison L Bayer
Journal:  Curr Diab Rep       Date:  2016-11       Impact factor: 4.810

8.  NK cells and gammadelta T cells mediate resistance to polyomavirus-induced tumors.

Authors:  Rabinarayan Mishra; Alex T Chen; Raymond M Welsh; Eva Szomolanyi-Tsuda
Journal:  PLoS Pathog       Date:  2010-05-27       Impact factor: 6.823

9.  Chemokine receptor expression in tumour islets and stroma in non-small cell lung cancer.

Authors:  Chandra M Ohri; Aarti Shikotra; Ruth H Green; David A Waller; Peter Bradding
Journal:  BMC Cancer       Date:  2010-04-29       Impact factor: 4.430

10.  Inflammatory cytokine-mediated evasion of virus-induced tumors from NK cell control.

Authors:  Rabinarayan Mishra; Bojan Polic; Raymond M Welsh; Eva Szomolanyi-Tsuda
Journal:  J Immunol       Date:  2013-06-14       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.